Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
CAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil.
Eur J Hum Genet. 2019 Aug;27(8):1235-1243. doi: 10.1038/s41431-019-0383-8. Epub 2019 Mar 26.
Intellectual disability (ID), megalencephaly, frontal predominant pachygyria, and seizures, previously called "thin" lissencephaly, are reported to be caused by recessive variants in CRADD. Among five families of different ethnicities identified, one homozygous missense variant, c.509G>A p.(Arg170His), was of Finnish ancestry. Here we report on the phenotypic variability associated for this potential CRADD founder variant in 22 Finnish individuals. Exome sequencing was used to identify candidate genes in Finnish patients presenting with ID. Targeted Sanger sequencing and restriction enzyme analysis were applied to screen for the c.509G>A CRADD variant in cohorts from Finland. Detailed phenotyping and genealogical studies were performed. Twenty two patients were identified with the c.509G>A p.(Arg170His) homozygous variant in CRADD. The majority of the ancestors originated from Northeastern Finland indicating a founder effect. The hallmark of the disease is frontotemporal predominant pachygyria with mild cortical thickening. All patients show ID of variable severity. Aggressive behavior was found in nearly half of the patients, EEG abnormalities in five patients and megalencephaly in three patients. This study provides detailed data about the phenotypic spectrum of patients with lissencephaly due to a CRADD variant that affects function. High inter- and intrafamilial phenotypic heterogeneity was identified in patients with pachygyria caused by the homozygous CRADD founder variant. The phenotype variability suggests that additional genetic and/or environmental factors play a role in the clinical presentation. Since frontotemporal pachygyria is the hallmark of the disease, brain imaging studies are essential to support the molecular diagnosis for individuals with ID and a CRADD variant.
智力障碍(ID)、巨脑、额部为主的脑回肥厚和癫痫,以前称为“薄”脑回畸形,据报道是由 CRADD 的隐性变异引起的。在确定的五个不同种族的家族中,一个纯合错义变异 c.509G>A p.(Arg170His) 具有芬兰血统。在这里,我们报告了与这种潜在的 CRADD 启动子变异相关的表型变异性,该变异存在于 22 名芬兰个体中。外显子组测序用于鉴定具有 ID 的芬兰患者的候选基因。靶向 Sanger 测序和限制酶分析应用于在芬兰的队列中筛选 c.509G>A CRADD 变体。进行了详细的表型和系谱研究。在 22 名患者中鉴定出 CRADD 中的 c.509G>A p.(Arg170His) 纯合变异。大多数祖先来自芬兰东北部,表明存在一个启动子效应。该疾病的标志是额颞部为主的脑回肥厚,伴有轻度皮质增厚。所有患者均表现出不同严重程度的 ID。近一半的患者存在攻击性行为,五名患者存在 EEG 异常,三名患者存在巨脑。本研究提供了有关 CRADD 变异引起的无脑回畸形患者表型谱的详细数据,该变异会影响功能。在由纯合 CRADD 启动子变异引起的脑回肥厚患者中发现了高的个体间和个体内表型异质性。表型变异性表明,其他遗传和/或环境因素在临床表现中起作用。由于额颞部脑回肥厚是该疾病的标志,脑成像研究对于支持 ID 和 CRADD 变异个体的分子诊断至关重要。